Comparing Canakinumab vs Kineret
| Canakinumab | Kineret (anakinra) |
|
|---|
| Canakinumab | Kineret (anakinra) |
|
|||||||
|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Cryopyrin-Associated Periodic Syndromes, Familial Cold Autoinflammatory Syndrome, Familial Mediterranean Fever, Gout - Acute, Hyperimmunoglobulin D Syndrome, Juvenile Idiopathic... View more |
Prescription only
Prescribed for Cryopyrin-Associated Periodic Syndromes, Rheumatoid Arthritis, COVID-19, Interleukin-1 Receptor Antagonist Deficiency. Kineret may also be used for purposes not listed in this medication guide. View more |
Related suggestions Cryopyrin-Associated Periodic Syndromes
|
|||||||
| More about Canakinumab | More about Kineret (anakinra) | ||||||||
| Ratings & Reviews | |||||||||
|
Canakinumab has an average rating of 10.0 out of 10 from a total of 5 ratings on Drugs.com. 100% of reviewers reported a positive effect, while 0% reported a negative effect. |
Kineret has an average rating of 9.0 out of 10 from a total of 10 ratings on Drugs.com. 90% of reviewers reported a positive effect, while 0% reported a negative effect. |
||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||||||||
|
View all Canakinumab side effects |
View all Kineret side effects |
||||||||
| Drug Class | |||||||||
| Generic Availability | |||||||||
|
N/A |
N/A |
||||||||
| Pricing and Coupons * Prices are without insurance | |||||||||
|
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
View all Kineret prices |
||||||||
| Dosage Forms | |||||||||
|
N/A |
|
||||||||
| Brand Names | |||||||||
| Ilaris |
N/A |
||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||||||||
|
624 hours |
6 hours |
||||||||
| CSA Schedule 1 View glossary of CSA terms | |||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||
| Pregnancy Category | |||||||||
|
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category B
No proven risk in humans
See the full pregnancy warnings document. |
||||||||
| Drug Interactions | |||||||||
|
A total of 519 drugs are known to interact with Canakinumab:
|
A total of 520 drugs are known to interact with Kineret:
|
||||||||
| Alcohol/Food/Lifestyle Interactions | |||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||
| Disease Interactions | |||||||||
| First Approval Date | |||||||||
|
N/A |
November 14, 2001 |
||||||||
| WADA Class View classifications | |||||||||
|
N/A |
N/A |
||||||||
| More Information | |||||||||
| Patient Resources | |||||||||
| Professional Resources | |||||||||
| Related Treatment Guide | |||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Colcrys
Colcrys is used to treat gout in adults and Familial Mediterranean Fever in adults and children ...
Ilaris
IIlaris (canakinumab) treats certain types of periodic fever syndromes, Still’s Disease, and gout f ...
Dupixent
Dupixent is used to treat eczema, eosinophilic or oral-corticosteroid-dependent asthma, chronic ...
Lodoco
Lodoco (colchicine) is used for cardiovascular disease to reduce the risk of heart attack, stroke ...
Arcalyst
Arcalyst (rilonacept) is used to treat Cryopyrin-Associated Periodic Syndromes, Deficiency of ...
Rilonacept
Rilonacept is used for cryopyrin-associated periodic syndromes, familial cold autoinflammatory ...
Colchicine
Colchicine is a plant-based alkaloid that may be used to treat and prevent gout and some other ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.